Main Calendar
2025 Iowa Biotech Showcase and Conference (IBSC)
The Iowa Biotech Showcase & Conference (IBSC) is an annual conference hosted by IowaBio bringing together innovators, biotech leaders, investors, and support vendors from across Iowa for industry-specific programming and networking opportunities. The ...
Legislative Update Call: First Funnel
9:00 AM - 9:30 AM
Join Jessica Hyland for the latest updates on what's happening up at the Iowa Capitol.
G2G’s March GBG Reporting Service Webinar
11:00 AM - 12:00 PM
Every third Thursday of the month, G2G hosts this online event to give bioscience companies (e.g. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities.
State Science Technology Fair of Iowa
The Iowa 4-H Youth Development’s State Science + Technology Fair of Iowa (SSTFI) serves as a platform for student researchers (grades 6 – 12) to meet with professional researchers and communicate their findings and understanding of the research process. Th
Legislative Update Call: Second Funnel
9:00 AM - 9:30 AM
Join Jessica Hyland for the latest updates on what's happening up at the Iowa Capitol.
IowaBio BioVantage Program Overview: Spring 2025
12:00 PM - 1:00 PM
Join us for a webinar to learn about the BioVantage savings program! The BioVantage program is one of IowaBio's top membership benefits by allowing our members access to incredible savings with our contract vendors. These savings ...
G2G’s April GBG Reporting Service Webinar
11:00 AM - 12:00 PM
Every third Thursday of the month, G2G hosts this online event to give bioscience companies (e.g. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities.
Q2 IowaBio Board Meeting
9:00 AM - 2:00 PM
Please hold this date for our Q2 Board Meeting. Location and exact time will be provided at a later date.
G2G’s May GBG Reporting Service Webinar
11:00 AM - 12:00 PM
Every third Thursday of the month, G2G hosts this online event to give bioscience companies (e.g. therapeutics, diagnostics, medical device, digital health, etc.) the chance to learn about non-dilutive funding opportunities.